New Harbor Capital and Origami Capital Recapitalize LGM Pharma

Origami Capital Recapitalizes Growth Equity Fund and Purchases Interests in Healthcare Portfolio Company

March 24, 2021

Financial Services

Origami Capital Partners completed a multifaceted recapitalization of a growth equity fund, converting it into a continuation vehicle, purchasing interests in an existing healthcare portfolio company from legacy investors (in partnership with the fund manager), and refinancing and upsizing a NAV facility. The firm committed more than $50 million to facilitate the transaction and gained exposure to a diversified set of assets across payments, education, software and healthcare.

Origami Capital Partners Provides Growth Capital to Coromandel Capital

July 17, 2025

Financial Services

Origami Capital Partners announced a strategic partnership with Coromandel Capital under which Origami will provide capital and support to accelerate Coromandel’s lending programs and scale its origination capacity. Coromandel, a Los Angeles-based private credit firm focused on asset-backed lending for FinTech and specialty finance, will continue to focus on self-liquidating asset pools with Origami’s backing.

LGM Pharma Acquires Nexgen Pharma's Drug Product CDMO Business

July 23, 2020

Pharmaceuticals

LGM Pharma has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, expanding LGM's CDMO capabilities and U.S.-based manufacturing footprint. Financial support for the transaction was provided by private equity firm New Harbor Capital; Nexgen Pharma sold its pharmaceutical CDMO unit to allow the company to focus on other healthcare segments.

Origami Capital Partners and Kestrel Partners Recapitalize UK Tech Portfolio

June 24, 2025

Software

Origami Capital Partners has formed a strategic partnership with London-based Kestrel Partners to recapitalize and invest in Kestrel's UK small-cap technology portfolio. Origami will provide hybrid, structured capital to support growth, liquidity and ownership transitions across the portfolio companies.

New Harbor Capital Makes Majority Growth Investment in FoodPharma

June 8, 2021

Food & Beverage

New Harbor Capital completed a majority growth equity investment in Food Technology and Design, LLC (dba FoodPharma), an R&D-focused contract manufacturer of functional and nutritional foods. New Harbor will partner with founder and CEO Glen Marinelli to expand the company’s product categories, capabilities, customers and geographies; FoodPharma operates two California facilities and employs over 90 people.

New Harbor Capital Recapitalizes Quigley Eye Specialists

February 13, 2020

Healthcare Services

New Harbor Capital completed a recapitalization of Quigley Eye Specialists, a Fort Myers, Florida-based ophthalmology and optometry practice with eight clinics and an ambulatory surgery center. The transaction closed January 24, 2020; existing leadership including founder Dr. Thomas Quigley and CEO Mark Quigley will remain in place as partners with New Harbor to fund growth, technology upgrades and regional expansion.